Mussolin L, Pillon M, d'Amore E S, Santoro N, Lombardi A, Fagioli F, Zanesco L, Rosolen A
Clinica di Oncoematologia Pediatrica, Azienda Ospedaliera-Università di Padova, Padova, Italy.
Leukemia. 2005 Sep;19(9):1643-7. doi: 10.1038/sj.leu.2403888.
Anaplastic large cell lymphoma (ALCL) harbors the reciprocal chromosomal translocation t(2;5)(p23;q35) in approximately 80% of the cases. The genes involved are nucleophosmin (NPM) and anaplastic lymphoma kinase (ALK) and the resulting chimeric NPM-ALK protein is thought to play a key role in the pathogenesis of t(2;5) positive ALCL. Few data on bone marrow (BM) involvement in ALCL have been published and they mostly rely on morphological examination of BM smears. We studied 52 ALCL for NPM-ALK expression by RT-PCR: 47/52 biopsies were positive. In 41 of the 47 cases we obtained the BM at diagnosis and investigated the prevalence of minimal BM infiltration by RT-PCR and real-time PCR. Minimal disseminated disease was positive in 25/41 patients (61%), of whom six had morphologically infiltrated BM. Survival analysis demonstrated a 5-year progression-free survival of 41 +/- 11% for patients with molecularly positive BM vs 100% for patients with negative BM (P = 0.001). These results suggest that minimal BM involvement at diagnosis is a common event in pediatric ALCL and that minimal BM disease monitoring could identify patients at risk of relapse.
间变性大细胞淋巴瘤(ALCL)在大约80%的病例中存在相互易位的染色体t(2;5)(p23;q35)。涉及的基因是核磷蛋白(NPM)和间变性淋巴瘤激酶(ALK),由此产生的嵌合NPM-ALK蛋白被认为在t(2;5)阳性ALCL的发病机制中起关键作用。关于ALCL骨髓(BM)受累的资料很少,且大多依赖于骨髓涂片的形态学检查。我们通过逆转录聚合酶链反应(RT-PCR)研究了52例ALCL的NPM-ALK表达情况:52例活检中有47例呈阳性。在这47例中的41例中,我们在诊断时获取了骨髓,并通过RT-PCR和实时PCR研究了微小骨髓浸润的发生率。微小播散性疾病在25/41例患者(61%)中呈阳性,其中6例骨髓有形态学浸润。生存分析显示,分子学上骨髓阳性的患者5年无进展生存率为41±11%,而骨髓阴性的患者为100%(P = 0.001)。这些结果表明,诊断时微小骨髓受累在儿童ALCL中是常见事件,且监测微小骨髓疾病可识别有复发风险的患者。